Ever Source Wealth Advisors, LLC Viridian Therapeutics, Inc.\De Call Options Transaction History
Ever Source Wealth Advisors, LLC
- $1.66 Billion
- Q1 2025
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|---|---|---|---|---|
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
Others Institutions Holding VRDN
# of Institutions
188Shares Held
79.7MCall Options Held
92.2KPut Options Held
55.2K-
Deep Track Capital, LP Greenwich, CT5.38MShares$91.3 Million2.54% of portfolio
-
Black Rock Inc. New York, NY4.77MShares$81 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ4.7MShares$79.7 Million5.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.56MShares$77.4 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY3.88MShares$65.9 Million12.64% of portfolio
About Viridian Therapeutics, Inc.\DE
- Ticker VRDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,888,900
- Market Cap $677M
- Description
- Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...